Beam Therapeutics Inc.BEAMNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+79.2%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+79.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
5.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$303.70M+681.4%
2024$38.87M-14.3%
2023$45.32M-14.2%
2022$52.80M+141.9%
2021$21.83M+135.3%
2020$-61.83M-1849.3%
2019$-3.17M+95.5%
2018$-71.00M-53244.7%
2017$-133091.00-